{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intravenous Magnesium in Remifentanil-Based Anesthesia"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "comparing intravenous magnesium to placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses whether intravenous magnesium, an NMDA receptor antagonist, can reduce postoperative pain and analgesic needs in adults receiving remifentanil-based anesthesia."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were postoperative analgesic requirements and pain scores within 24 hours."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty-two RCTs involving 1362 participants were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Magnesium significantly decreased 24-hour analgesic requirements (SMD \u22121.51; 95% CI \u22122.15 to \u22120.87; p < 0.0001) and pain scores (SMD \u22120.61; 95% CI \u22120.90 to \u22120.32; p < 0.0001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were not significantly different between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The study was registered on PROSPERO (CRD42024609911)."
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was funded by institutional grants."
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}